Article révisé par les pairs
Titre:
  • Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.
Auteur:Manns, Michael; Reesink, Henk; Berg, Thomas; Dusheiko, Geoffrey; Flisiak, Robert; Marcellin, P; Moreno, Christophe; Lenz, Oliver; Meyvisch, Paul; Peeters, Monika P.; Sekar, Vanitha; Simmen, Kenneth; Verloes, René
Informations sur la publication:Antiviral therapy, 16, 7, page (1021-1033)
Statut de publication:Publié, 2011
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Adult
Aged
Antiviral Agents -- administration & dosage -- adverse effects -- therapeutic use
Bilirubin -- analysis
Double-Blind Method
Drug Therapy, Combination
Female
Genotype
Hepacivirus -- drug effects
Hepatitis C -- drug therapy -- virology
Heterocyclic Compounds, 3-Ring -- administration & dosage -- adverse effects -- therapeutic use
Humans
Interferon-alpha -- administration & dosage -- therapeutic use
Male
Middle Aged
Polyethylene Glycols -- administration & dosage -- therapeutic use
Protease Inhibitors -- administration & dosage -- adverse effects -- therapeutic use
RNA, Viral -- blood
Recombinant Proteins -- administration & dosage -- therapeutic use
Ribavirin -- administration & dosage -- pharmacology -- therapeutic use
Sulfonamides -- administration & dosage -- adverse effects -- therapeutic use
Viral Load
Note générale:Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1359-6535
info:doi/10.3851/IMP1894
info:scp/80055076797
info:pmid/22024518

Documents en relation

DI-fusion